• Contact Us
Pharmaceuticals & Life Sciences Blogs - VWV

Pharma & Life Sciences

Articles & Blogs Coronavirus (Covid-19) Pharma & Life Sciences

Coronavirus Will Not Be Eradicated, SAGE Expert Warns

Wednesday, 16 September 2020

Coronavirus (COVID-19) will not be eradicated, and repeat vaccines will be needed to help the population through, Professor Sir Mark Walport, a member of SAGE (the Government's Scientific Advisory Group for Emergencies) has warned.

Coronavirus Will Not Be Eradicated, SAGE Expert Warns

Articles & Blogs Coronavirus (Covid-19) Pharma & Life Sciences

AstraZeneca Announces Latest Bold Step Towards COVID-19 Antibody Treatment

Wednesday, 12 August 2020

Anglo-Swedish Big Pharma company, AstraZeneca, has announced the first round of in-human Phase I trials for its revolutionary coronavirus (COVID-19) antibody treatment, developed in collaboration with Vanderbilt University in the US.

AstraZeneca Announces Latest Bold Step Towards COVID-19 Antibody Treatment

Articles & Blogs Pharma & Life Sciences

Consultation Period on ABPI Code Closing Soon - Have Your Say

Tuesday, 11 August 2020

The Association of the British Pharmaceutical Industry (ABPI) Code of Practice is currently in a review and update process, intended to produce a revised version of the Code which will have effect from 1 July 2021.

Consultation Period on ABPI Code Closing Soon - Have Your Say

Articles & Blogs Coronavirus (Covid-19) Pharma & Life Sciences

Indian Business Invents Device That 'Disables' Air and Surface-Borne Coronavirus

Tuesday, 04 August 2020

Indian media outlets have reported that a Bengalaru-based business, Shreis Scalene Therapeutics, has developed a prototype device that can disable the human to human transmission of the Corona family of viruses, including COVID-19.

Indian Business Invents Device that 'Disables' Air and Surface-Borne Coronavirus

Articles & Blogs Pharma & Life Sciences

No Business, Like Brexit Business

Monday, 27 July 2020

As Brexit talks intensify, healthcare practices from both the UK and EU need to consider and aim to prepare for all scenarios.

No Business, Like Brexit Business

Articles & Blogs Coronavirus (Covid-19) Pharma & Life Sciences

What Is The Value of Community Pharmacy in England under COVID-19?

Monday, 27 July 2020

Whilst the Government has been singing the praises of workers in the NHS, particularly those working in hospitals, one sector of health professionals that have been working throughout the pandemic has hardly received a mention.

No Business, Like Brexit Business

Articles & Blogs Commercial Contracts Coronavirus (Covid-19) Pharma & Life Sciences

Force Majeure Clause May Be Unreliable If Circumstances Are Within Reasonable Control

Thursday, 09 July 2020

Force majeure clauses have risen from ignored boilerplate clauses to top of the agenda due to coronavirus (COVID-19). The High Court has ruled against a party looking to rely on a force majeure clause...

Force Majeure Clause May Be Unreliable If Circumstances are Within Reasonable Control

Articles & Blogs Commercial Contracts Pharma & Life Sciences

How Can an Innocent Party Take Action to Enforce Their Contractual Rights?

Thursday, 09 July 2020

What should an innocent party do if they are looking to take action against a late paying customer without breaching the contract itself?

How Can an Innocent Party Take Action to Enforce Their Contractual Rights?

Articles & Blogs Healthcare Pharma & Life Sciences

Why Is the GPhC Receiving More Fitness to Practise Concerns?

Tuesday, 07 July 2020

The massive number of fitness to practise (FtP) concerns the GPhC has received are likely to be the result of the coronavirus (COVID-19) pandemic, says lawyer Andrew Andrews.

The GPhC Is Clamping Down on Online Pharmacy Owners

Articles & Blogs Pharma & Life Sciences

No Business, Like Brexit Business

Monday, 06 July 2020

As Brexit talks intensify, bio/pharma companies from both the UK and EU need to consider and aim to prepare for all scenarios.

No Business, Like Brexit Business

Articles & Blogs Coronavirus (Covid-19) Information Law Pharma & Life Sciences

No Data Protection Impact Assessment Conducted on Coronavirus Test and Trace

Thursday, 11 June 2020

The Open Rights Group (ORG) has filed a complaint with the Information Commissioner's Office about the NHS test and trace service. The complaint relates to the fact that a Data Protection Impact Assessment (DPIA) has not been carried out.

No Data Protection Impact Assessment Conducted on Coronavirus Test and Trace

Articles & Blogs Coronavirus (Covid-19) Pharma & Life Sciences

UK Shows Itself As Leader in the Fight Against Coronavirus

Thursday, 11 June 2020

On 4 June 2020, the UK hosted the Global Vaccine Summit, at which Boris Johnson told attendees that events such as these were vital to the fight against coronavirus (COVID-19).

UK Shows Itself As Leader in the Fight Against Coronavirus

Articles & Blogs Coronavirus (Covid-19) Pharma & Life Sciences

Genomics England Takes the Fight Against Coronavirus to the Genetic Level

Thursday, 11 June 2020

Genomics England has announced a new nationwide programme in which it will seek to study the genetic factors which play a part in an individual's susceptibility to coronavirus (COVID-19).

Genomics England Takes the Fight Against Coronavirus to the Genetic Level

Articles & Blogs Coronavirus (Covid-19) Pharma & Life Sciences

UK Life Sciences Organisations to Share in €117m of Coronavirus Research Funding

Monday, 01 June 2020

Six UK-based organisations are to receive a share in €117m worth of research funding that has been awarded to eight collaborative research projects focused on the "development of therapeutics and diagnostics which are aimed at combatting coronavirus".

UK Life Sciences Organisations to Share in €117m of Coronavirus Research Funding

Articles & Blogs Coronavirus (Covid-19) Pharma & Life Sciences

UK Life Sciences Industry Commits to Fighting Coronavirus and Supporting Patients

Thursday, 21 May 2020

A bold statement of intent has been issued by trade bodies representing organisations across the entire UK life sciences industry. The statement expresses the industry's strong commitment to fighting coronavirus (COVID-19) and supporting NHS patients.

UK Life Sciences Industry Commits to Fighting Coronavirus and Supporting Patients